New therapies for managing aging could emerge from research into a new gene, which scientists have identified as a key driver of degeneration. Age-related diseases are strongly linked to inflammation which, when chronic, albeit low-grade, contributes to conditions such as cardiovascular disease, diabetes, neurodegeneration, and sarcopenia. In a study, Dr. Ildus Akhmetov uncovered groundbreaking insights into the role of the Ectodysplasin A2 Receptor (EDA2R) in this process. EDA2R, a member of the tumor necrosis factor receptor family, specifically binds to the EDA-A2 protein and is involved in apoptosis, or cell death, and inflammatory signaling. The team identified a striking, tissue-independent...